Univ. Lille, CNRS, UMR 8576, UGSF, Unité de Glycobiologie Structurale et Fonctionnelle, 59000, Lille, France.
Chembiochem. 2021 Dec 10;22(24):3381-3390. doi: 10.1002/cbic.202100363. Epub 2021 Sep 14.
The Sd carbohydrate antigen and the corresponding biosynthetic enzyme B4GALNT2 are primarily expressed in human normal colonic mucosa and are down-regulated to variable degrees in colon cancer. On the other hand, the tumor associated antigen SLe is not detected in the healthy colon and is upregulated in colon cancer. High level of B4GALNT2 gene expression appears to be a good marker of prognosis in colon cancer; however, the molecular mechanisms regulating these carbohydrate antigens' expression are still poorly understood. We review here the most recent progress made towards understanding this balanced expression of blood group carbohydrate epitopes Sd and SLe . In particular in recent years, we have attained a better understanding of genetic and epigenetic regulation of the B4GALNT2 gene and of the subcellular fate of B4GALNT2 isoforms.
Sd 碳水化合物抗原及其相应的生物合成酶 B4GALNT2 主要在人正常结肠黏膜中表达,并在结肠癌中不同程度地下调。另一方面,肿瘤相关抗原 SLe 在健康结肠中检测不到,而在结肠癌中上调。B4GALNT2 基因表达水平高似乎是结肠癌预后的一个良好标志物;然而,调节这些碳水化合物抗原表达的分子机制仍知之甚少。我们在此回顾了在理解 Sd 和 SLe 血型碳水化合物表位平衡表达方面取得的最新进展。特别是近年来,我们对 B4GALNT2 基因的遗传和表观遗传调控以及 B4GALNT2 同工型的亚细胞命运有了更好的理解。